| HOME >> MEDICINE >> TECHNOLOGY |
FORT WORTH, Texas, April 18, 2011 /PRNewswire/ -- Two lawsuits were filed today on behalf of plaintiffs whose ASR Acetabular Hip Replacement Systems have failed. The cases were filed on behalf of Robert and LaDonna Rankin, and by Tina Presley against DePuy Orthopaedics, Inc., DePuy Inc., DePuy International, Ltd., Johnson & Johnson, Inc., Johnson & Johnson Services, Inc. and Johnson & Johnson International, Inc. John David Hart of the Law Offices of John David Hart in Fort Worth, Texas, is the attorney representing the plaintiffs in the individual lawsuits filed in the United States District Court for the Northern District of Texas.
DePuy Orthopaedics, Inc., a division of Johnson and Johnson, Inc., recalled its ASR Acetabular Metal-on-Metal Hip Replacement System on August 24, 2010. This recall came after data from a recent study indicated that the five year failure rate of this product is approximately 13%, or more than 1 out of every 8 patients. DePuy identified reasons for the failure of the hip replacement system as component loosening, component malalignment, infection, fracture of the bone, dislocation, metal sensitivity and pain. Additional complications from the DePuy ASR Acetabular Hip Replacement System may include increased metal ion levels in the blood, bone staining, necrosis, swelling, nerve damage, tissue damage and/or muscle damage. This device was marketed by DePuy Orthopaedics as a high performance hip replacement system. However, recent information published by the British Orthopaedic Association indicates that failure rates at six years may be as high as 49%.
"The number of people affected by this dangerous medical device is astounding," said attorney John David Hart. "The consequences of these failed, recalled devices have been extensive and devastating. There will be serious long term health implications to patients who have had these recalled, defective devices."
John David Hart and t
'/>"/>
| SOURCE Law Offices of John David Hart Copyright©2010 PR Newswire. All rights reserved |